$0.4332
0.01212.87%
Last update: Nov 9, 7:12 PM
Boqii fell 82.7% from $2.50 to $0.43, behind the S&P 500's +10.5%. Its worst day was Nov 12 (−17.3%), and its low came Nov 6 at $0.42.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Boqii closed at its highest level of the year, 4.0% above where the year started.
+4.0% · S&P 500 +0.2%
Boqii shares rose 29.5%, while the S&P 500 rose 0.7%.
+29.5% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
Boqii shares surged in after-hours trading following the announcement of a $1.76 million equity repurchase by the founders of Nanjing Xingmu Biotechnology.
+20.0% · S&P 500 +0.2%
EPS of $-0.53 was reported on $29.2M revenue.
−2.2% · S&P 500 +0.6%
Boqii shares rose 21.3%, while the S&P 500 rose 1.0%.
+21.3% · S&P 500 +1.0%
Boqii shares rose 36.0%, while the S&P 500 rose 1.7%.
+36.0% · S&P 500 +1.7%
EPS of $-0.21 was reported on $61.0M revenue.
−4.3% · S&P 500 +0.4%
Boqii shares rose 52.4%, while the S&P 500 rose 0.3%.
+52.4%, the year's best day, on 120M shares, the year's heaviest volume · S&P 500 +0.3%
Where it ended: a close of $0.43 on Nov 9, 2026. Up next: H1 2027 earnings on Jan 4, 2027.
Nothing in the past 12 months.
All BQ analyst actionsNothing in the past 12 months.
All BQ dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BQ and SPY from Benzinga historical bars. Not investment advice.
